TLR-2 gene Arg753Gln polymorphism is strongly associated with acute rheumatic fever in children

Journal of Molecular Medicine

Volumn 83, Issue 7, 2005, Pages 535-541

  Berdeli, Afig ^a   Celik, Handan Ak ^b   Özyürek, Ruhi ^b   Dogrusoz, Buket ^b   Aydin, Hikmet Hakan ^b  

^a EGE UNIVERSITY SCHOOL OF MEDICINE   (Turkey)

^b EGE UNIVERSITY   (Turkey)

Author keywords

Acute rheumatic fever; Gene polymorphism; Infections; Single nucleotide polymorphism; TLR 2

Indexed keywords

AGAROSE; ANTISTREPTOLYSIN; C REACTIVE PROTEIN; ETHIDIUM BROMIDE; GENOMIC DNA; TOLL LIKE RECEPTOR 2;

ADOLESCENT; ARTICLE; CAUCASIAN; COMPARATIVE STUDY; CONFIDENCE INTERVAL; CONTROLLED STUDY; DISEASE ASSOCIATION; DNA EXTRACTION; EXTRACTION; FEMALE; GENE FREQUENCY; GENETIC ANALYSIS; GENETIC POLYMORPHISM; GENOTYPE; HUMAN; LEUKOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; PATHOGENESIS; POLYMERASE CHAIN REACTION; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; RHEUMATIC FEVER; SCHOOL CHILD; SEDIMENTATION; STANDARD; STATISTICAL SIGNIFICANCE;

ADULT; CASE-CONTROL STUDIES; CHILD; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; MALE; POLYMORPHISM, SINGLE NUCLEOTIDE; RHEUMATIC FEVER; TOLL-LIKE RECEPTOR 2; TURKEY;

EID: 23744442371     PISSN: 09462716     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00109-005-0677-x     Document Type: Article

References (45)

1. Kaplan E (1996) Recent epidemiology of group A streptococcal infections in North America and abroad: an overview. Pediatrics 97:S945-S948
2. Krishna Kumar R et al (1999) Epidemiology of streptococcal pharyngitis, rheumatic fever and rheumatic heart disease. In: Narula J et al (eds) Rheumatic fever. American Registry of Pathology, Washington, D.C., pp 41-78
3. Bisno AL (1996) Acute pharyngitis: etiology and diagnosis. Pediatrics 97:S949-S954
4. Shulman ST et al (2000) Streptococcal infections. In: Stevens D, Kaplan E (eds) Clinical aspects, microbiology, and molecular pathogenesis. Oxford University Press, New York, pp 76-101
5. World Health Organization (2004) Rheumatic fever and rheumatic heart disease: report of a WHO expert consultation. Geneva, 20 October-1 November 2001. World Health Organization, Albany, NY, USA
6. Stollerman GH (1997) Rheumatic fever. Lancet 349:935-942
7. Kaplan EL (1980) The group A streptococcal upper respiratory tract carrier state: an enigma. J Pediatr 97:337-345
8. Stollerman GH (2001) Rheumatic fever in the 21st century. Clin Infect Dis 33:806-814
9. Karaaslan S, Oran B, Reisli I, Erkul I (2000) Acute rheumatic fever in Konya, Turkey. Pediatr Int 42:71-75
10. Olgunturk R, Aydin GB, Tunaoglu FS, Akalin N (1999) Rheumatic heart disease prevalence among schoolchildren in Ankara, Turkey. Turk J Pediatr 41:201-206
11. Guilherme L, Kalil J (2002) Rheumatic fever: the T cell response leading to autoimmune aggression in the heart. Autoimmun Rev 1:261-266
12. Brewerton DA, Joseph J (1976) Bunim memorial lecture. HLA-B27 and the inheritance of susceptibility to rheumatic disease. Arthritis Rheum 19:656-668
13. Ebringer A, Wilson C (2000) HLA molecules, bacteria and autoimmunity. J Med Microbiol 49:305-311
14. Senitzer D, Freimer EH (1984) Autoimmune mechanisms in the pathogenesis of rheumatic fever. Rev Infect Dis 6:832-839
15. Weidebach W, Goldberg AC, Chiarella JM, Guilherme L, Snitcowsky R, Pileggi F, Kalil J (1994) HLA class II antigens in rheumatic fever. Analysis of the DR locus by restriction fragment-length polymorphism and oligotyping. Hum Immunol 40:253-258
16. Yoshinoya S, Pope RM (1980) Detection of immune complexes in acute rheumatic fever and their relationship to HLA-B5. J Clin Invest 65:136-145
17. Zwillich SH, Lipsky PE (1987) Molecular mimicry in the pathogenesis of rheumatic diseases. Rheum Dis Clin North Am 13:339-352
18. Chou HT, Chen CH, Tsai CH, Tsai FJ (2004) Association between transforming growth factor-beta 1 gene C-509T and T869C polymorphisms and rheumatic heart disease. Am Heart J 148:181-186
19. Berdeli A, Celik HA, Ozyurek R, Aydin HH (2004) Involvement of immunoglobulin FcgammaRIIA and FcgammaRIIIB gene polymorphisms in susceptibility to rheumatic fever. Clin Biochem 37:925-929
20. Malley R, Henneke P, Morse SC, Cieslewicz MJ, Lipsitch M, Thompson CM, Kurt-Jones E, Paton JC, Wessels MR, Golenbock DT (2003) Recognition of pneumolysin by toll-like receptor 4 confers resistance to pneumococcal infection. Proc Natl Acad Sci U S A 100:1966-1971
21. Knapp S, Wieland CW, Van Veer C, Takeuchi O, Akira S, Florquin S, van der Poll T (2004) Toll-like receptor 2 plays a role in the early inflammatory response to murine pneumococcal pneumonia but does not contribute to antibacterial defense. J Immunol 172:3132-3138
22. O'Neill LA (2004) TLRs: Professor Mechnikov, sit on your hat. Trends Immunol 25:687-693
23. Arbour NC, Lorenz E, Schutte BC, Zabner J, Kline JN, Jones M, Frees K, Watt JL, Schwartz DA (2000) TLR4 mutations are associated with endotoxin hyporesponsiveness in humans. Nat Genet 25:187-191
24. Kiechl S, Lorenz E, Reindl M, Wiedermann CJ, Oberhollenzer F, Bonora E, Willeit J, Schwartz DA (2002) Toll-like receptor 4 polymorphisms and atherogenesis. N Engl J Med 347:185-192
25. Fitzgerald KA, Palsson-McDermott EM, Bowie AG, Jefferies CA, Mansell AS, Brady G, Brint E, Dunne A, Gray P, Harte MT, McMurray D, Smith DE, Sims JE, Bird TA, O'Neill LA (2001) Mal (MyD88-adapter-like) is required for toll-like receptor 4 signal transduction. Nature 413:78-83
26. Horng T, Barton GM, Medzhitov R (2001) TIRAP: an adapter molecule in the toll signaling pathway. Nat Immunol 2:835-841
27. Schroder NW, Schumann RR (2005) Single nucleotide polymorphisms of toll-like receptors and susceptibility to infectious disease. Lancet Infect Dis 5:156-164
28. Lorenz E, Mira JP, Cornish KL, Arbour NC, Schwartz DA (2000) A novel polymorphism in the toll-like receptor 2 gene and its potential association with staphylococcal infection. Infect Immun 68:6398-6401
29. Hawn TR, Verbon A, Lettinga KD, Zhao LP, Li SS, Laws RJ, Skerrett SJ, Beutler B, Schroeder L, Nachman A, Ozinsky A, Smith KD, Aderem A (2003) A common dominant TLR5 stop codon polymorphism abolishes flagellin signaling and is associated with susceptibility to Legionnaires' disease. J Exp Med 198:1563-1572
30. Medvedev AE, Lentschat A, Kuhns DB, Blanco JC, Salkowski C, Zhang S, Arditi M, Gallin JI, Vogel SN (2003) Distinct mutations in IRAK-4 confer hyporesponsiveness to lipopolysaccharide and interleukin-1 in a patient with recurrent bacterial infections. J Exp Med 198:521-531
31. Picard C, Fuel A, Bonnet M, Ku CL, Bustamante J, Yang K, Soudais C, Dupuis S, Feinberg J, Fieschi C, Elbim C, Hitchcock R, Lammas D, Davies G, Al-Ghonaium A, Al-Rayes H, Al-Jumaah S, Al-Hajjar S, Al-Mohsen IZ, Frayha HH, Rucker R, Hawn TR, Aderem A, Tufenkeji H, Haraguchi S, Day NK, Good RA, Gougerot-Pocidalo MA, Ozinsky A, Casanova JL (2003) Pyogenic bacterial infections in humans with IRAK-4 deficiency. Science 299:2076-2079
32. Committee on Rheumatic Fever and Bacterial Endocarditis of the American Heart Association (1982) Jones criteria (revised) for guidance in the diagnosis of rheumatic fever. American Heart Association, Dallas, TX, USA
33. Schröder NW, Hermann C, Hamann L, Göbel UB, Hartung T, Schumann RR (2003) High frequency of polymorphism Arg753Gln of the toll-like receptor 2 gene detected by a novel allele-specific PCR. J Mol Med 81:368-372
34. World Health Organization (1988) Rheumatic fever and rheumatic heart disease. Report of a WHO Study Group. World Health Organization, Geneva (Technical Report Series No. 764)
35. Taranta A, Markowitz M (1989) Rheumatic fever. Kluwer, Boston, pp 19-25
36. Stevens D, Kaplan E (2000) Streptococcal infections. Clinical aspects, microbiology and molecular pathogenesis. Oxford University Press, New York, pp 102-132
37. Simpson WA, Courtney HS, Ofek I (1987) Interactions of fibronectin with streptococci: the role of fibronectin as a receptor for Streptococcus pyogenes. Rev Infect Dis 9:S351-S359
38. Kotb M, Watanabe-Ohnishi R, Wang B (1993) Analysis of the TCRV beta specificities of bacterial superantigens using PCR. ImmunoMethods 2:33-40
39. Underhill DM (2004) Toll-like receptors and microbes take aim at each other. Curr Opin Immunol 16:483-487
40. Schwandner R, Dziarski R, Wesche H, Rothe M, Kirschning CJ (1999) Peptidoglycan and lipoteichoic acid-induced cell activation is mediated by toll-like receptor 2. J Biol Chem 274: 17406-17409
41. Schröder NW, Opitz B, Lamping N, Michelsen KS, Zähringer U, Göbel UB, Schumann RR (2000) Involvement of lipopolysaccharide binding protein, CD14, and toll-like receptors in the initiation of innate immune responses by Treponema glycolipids. J Immunol 165:2683-2693
42. Hirschfeld M, Kirschning CJ, Schwandner R, Wesche H, Weis JH, Wooten RM, Weis JJ (1999) Cutting edge: inflammatory signaling by Borrelia burgdorferi lipoprotein is mediated by toll-like receptor 2. J Immunol 163:2382-2386
43. Takeuchi O, Kaufmann A, Grote K, Kawai T, Hoshino K, Morr M, Mühlradt PF, Akira S (2000) Cutting edge: preferentially the R-stereoisomer of the mycoplasmal lipopeptide macrophage-activating lipopeptide-2 activates immune cells through a toll-like receptor 2 and MYD88-dependent signaling pathway. J Immunol 164:554-557
44. Takeuchi O, Akira S (2002) Genetic approaches to the study of toll-like receptor function. Microbes Infect 4:887-895
45. Kang TJ, Chae GT (2001) Detection of toll-like receptor 2 (TLR2) mutation in the lepromatous leprosy patients. FEMS Immunol Med Microbiol 31:53-58